NEFL and prostate carcinoma: Overall, we show that NEFL expression occurs in a subset of prostate cancer cells with neuroendocrine-like phenotype that is associated with aggressive prostate cancer and siRNA silencing of NEFL inhibits the migration and invasion potential of PC3-ML2 cells.